Fig. 10. ROS production in breast cancer cells upon 4 h treatment with 50 μg mL⁻¹ each of ZnO NPs, CUR and Zn(CUR)O nanocomposites (control treated with solvent was set at 100 relative fluorescence intensity). ***/**/* vs. control (DMSO); ^○○○/^○○/^○vs. ZnO; ###/##/# vs. Zn(CUR)O-C; +++/++/+ vs. Zn(CUR)O-B; */°/#/+ p < 0.05; **/^○○/##/++ p < 0.01; ***/^○○○/##/+++ p < 0.001.